Litcius/Paper detail

Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors

Jun He, Lijun Hu, Xiaojun Huang, Chenran Wang, Zhimin Zhang, Ying Wang, Dongmei Zhang, Wen‐Cai Ye

2020International Journal of Antimicrobial Agents114 citationsDOIOpen Access PDF

Topics & Concepts

CoronavirusCoronaviridaeProteaseBetacoronavirusVirologyMiddle East respiratory syndrome coronavirusPolyproteinsBiologyViral replicationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseMedicineCoronavirus disease 2019 (COVID-19)VirusInfectious disease (medical specialty)EnzymePathologyBiochemistrySARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsCOVID-19 Clinical Research Studies
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors | Litcius